Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs sevoflurane anesthesia and postoperative sleep in laparoscopic colorectal cancer surgery
ChiCTR2500111562Phase 4Not yet recruiting
- Sponsor
- Jianyang People's Hospital
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in sleep disorder and colorectal cancer (CRC) (2 arms), sponsored by Jianyang People's Hospital. Primary endpoint: Incidence of sleep disturbances 1 day after surgery. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
sleep disordercolorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2500111562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111562.